
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
The most effective method to Pick the Right Old Consideration Administration: Key Contemplations - 2
She loves to give experiences. He goes for sentimental gifts. They ask an expert: What is the perfect holiday present? - 3
74 suicide warnings and 243 mentions of hanging: What ChatGPT said to a suicidal teen - 4
Understanding the Rudiments of Tree Administrations - 5
The Leonid meteor shower is peaking early this week. Here’s what to know
James Webb Space Telescope finds strongest evidence yet for atmosphere around rocky exoplanet: 'It's really like a wet lava ball'
FDA updates risk classification for voluntary shredded cheese recall
Ukraine demands army of 800,000 under peace plan
West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
IDF destroys regime's missile, sea mine production site in Yazd amid nationwide airstrikes
Grasping the Qualifications Among Separation and Dissolution
Tehran defends ship seizure as a legal action, but tensions continue in the Gulf
German journalists' union condemns attack on reporters in village
Iranian-linked drone attack kills Kurdish couple in northern Iraq













